EP3630819
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.5.2018EP published:
11.10.2023EP application number:
18731616.1
EPO information:
European Patent Register
Max expiry date:
20.5.2038
Title in English:
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTSLanguage of the patent:
English
Timeline
Today
21.5.2018EP application
11.10.2023EP Publication
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
121 Seaport Boulevard, Boston, MA 02210, US
Inventor
Name:
ADIV, Orly, EshachAddress:
3030000 Atlit, IL
Name:
BEDROSIAN, CamilleAddress:
Woodbridge CT 06525, US
Name:
FELDMAN, Hagit, BarisAddress:
Boston MA 02210, US
Name:
KUROLAP, AlinaAddress:
3249516 Haifa, IL
Name:
MCKNIGHT, Susan, FaasAddress:
Old Lyme CT 06371, US
Priority
Number:
201762509576 PDate:
22.5.2017Country:
US
Classification
Categories:
C07K 16/18, C07K 16/40, A61K 39/00, C12Q 1/6883, G01N 33/68, A61P 1/00, A61P 3/00, A61P 7/00, A61P 9/00, A61P 37/00, G01N 33/574